T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SF
1251
Stifel
SF
$12.9B
| $4.39M | ﹤0.01% |
78,257
+459
| +0.6% | +$24.3K |
|
1252
Zillow
Z
$7.82B
| $4.39M | ﹤0.01% |
94,533
+5,270
| +6% | +$232K |
|
|
PYCR
1253
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $4.38M | ﹤0.01% |
344,648
-10,927
| -3% | -$163K |
|
1254
Amkor Technology
AMKR
$14.7B
| $4.37M | ﹤0.01% |
109,233
+2,767
| +3% | +$91.6K |
|
1255
Cabaletta Bio
CABA
$448M
| $4.36M | ﹤0.01% |
582,275
-30,123
| -5% | -$369K |
|
1256
Aura Biosciences
AURA
$795M
| $4.34M | ﹤0.01% |
573,640
-21,900
| -4% | -$160K |
|
1257
Robert Half
RHI
$4.42B
| $4.32M | ﹤0.01% |
67,430
-88,009
| -57% | -$6.04M |
|
1258
Donaldson
DCI
$11.1B
| $4.31M | ﹤0.01% |
60,217
-75
| -0.1% | -$5.5K |
|
|
GMS
1259
DELISTED
GMS Inc
GMS
| $4.31M | ﹤0.01% |
53,461
-764
| -1% | -$70.5K |
|
1260
Terex
TEX
$7.76B
| $4.31M | ﹤0.01% |
78,561
+3,079
| +4% | +$183K |
|
1261
UGI
UGI
$7.59B
| $4.29M | ﹤0.01% |
187,190
+68,243
| +57% | +$1.65M |
|
1262
Dolby
DLB
$5.84B
| $4.28M | ﹤0.01% |
54,022
-138
| -0.3% | -$11.1K |
|
1263
NNN REIT
NNN
$8.83B
| $4.28M | ﹤0.01% |
100,367
+3,836
| +4% | +$160K |
|
1264
Albertsons Companies
ACI
$6.03B
| $4.25M | ﹤0.01% |
215,189
+7,700
| +4% | +$157K |
|
1265
Qiagen
QGEN
$8.87B
| $4.23M | ﹤0.01% |
100,137
+10,923
| +12% | +$479K |
|
1266
HNI Corp
HNI
$3.53B
| $4.21M | ﹤0.01% |
93,495
+1,167
| +1% | +$51.5K |
|
1267
Sensata Technologies
ST
$6.73B
| $4.21M | ﹤0.01% |
112,555
+3,961
| +4% | +$153K |
|
1268
iShares Russell 1000 ETF
IWB
$50.4B
| $4.21M | ﹤0.01% |
14,136
-1,059
| -7% | -$304K |
|
1269
BioNTech
BNTX
$23.4B
| $4.2M | ﹤0.01% |
52,202
-393
| -0.7% | -$35.9K |
|
1270
California Water Service
CWT
$3.12B
| $4.19M | ﹤0.01% |
86,375
+1,326
| +2% | +$64.4K |
|
1271
Cullen/Frost Bankers
CFR
$10.6B
| $4.19M | ﹤0.01% |
41,198
+5,113
| +14% | +$536K |
|
1272
Gibraltar Industries
ROCK
$1.42B
| $4.17M | ﹤0.01% |
60,804
-153,346
| -72% | -$11.2M |
|
|
TMHC
1273
DELISTED
Taylor Morrison
TMHC
| $4.17M | ﹤0.01% |
75,185
-3,712
| -5% | -$212K |
|
1274
NOV
NOV
$7.54B
| $4.15M | ﹤0.01% |
218,502
-16,646
| -7% | -$312K |
|
1275
Teva Pharmaceuticals
TEVA
$42.8B
| $4.13M | ﹤0.01% |
254,129
+52,280
| +26% | +$805K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.